Share on StockTwits

Egalet Corp (NASDAQ:EGLT) Insider Mark Strobeck sold 5,135 shares of Egalet Corp stock on the open market in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $9.20, for a total value of $47,242.00. Following the sale, the insider now directly owns 125,280 shares of the company’s stock, valued at approximately $1,152,576. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Egalet Corp (NASDAQ:EGLT) traded up 0.54% during mid-day trading on Thursday, hitting $9.24. The stock had a trading volume of 14,372 shares. Egalet Corp has a 52-week low of $8.82 and a 52-week high of $19.85. The stock’s 50-day moving average is $12.07 and its 200-day moving average is $12.92. The company’s market cap is $146.8 million.

Egalet Corp (NASDAQ:EGLT) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.73) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.42) by $0.31. Analysts expect that Egalet Corp will post $-2.67 EPS for the current fiscal year.

Egalet Corporation is a specialty pharmaceutical company developing and focuses on commercializing, abuse-deterrent oral products for the treatment of pain and in other indications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.